Who are Macrogenics Inc's investors?

Macrogenics Inc's investors include Havencrest Capital Management, Ridgeback Capital, RiverVest Venture Partners, Sanofi Ventures.

Macrogenics Inc

NASDAQ: MGNX

Incorporated in Delaware · 4 known investors

MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.

Biotech Healthtech Medical Devices

Investors · 4

Havencrest Capital ManagementDallas

Ridgeback CapitalMiami

RiverVest Venture PartnersSt. Louis · $500K – $3M

Sanofi VenturesCambridge · $5M

Competitors · 1

by search overlap

Biogen Idec97 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

Companies competing with Macrogenics Inc for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Macrogenics Inc (MGNX)morningstar.com

Frequently asked questions

What does Macrogenics Inc do?: MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Who are Macrogenics Inc's investors?: Macrogenics Inc's investors include Havencrest Capital Management, Ridgeback Capital, RiverVest Venture Partners, Sanofi Ventures.